Clinical Oncology Next Generation Sequencing Ngs Market In-depth Research covering sales outlook, demand forecast & up-to-date key trends
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Clinical Oncology Next Generation Sequencing Ngs market is expected to grow at a CAGR of 11.0% during the forecast period.
The global Clinical Oncology Next Generation Sequencing Ngs market is estimated to be about 636.3 million US dollars in 2020.
The global Clinical Oncology Next Generation Sequencing Ngs market is estimated to reach 964.4 million USD by 2026.
The global Clinical Oncology Next Generation Sequencing Ngs market is segmented by company, region (country), type and application. Participants, stakeholders, and other readers in the global Clinical Oncology Next Generation Sequencing Ngs market will be able to gain an advantage as they use reports as a powerful resource.
Clinical Oncology Next Generation Sequencing Ngs markets by category
NGS Pre-Sequencing
Sequencing
NGS Data Analysis
Primary, Secondary & Tertiary Data Analysis
Clinical Oncology Next Generation Sequencing Ngs Market by Application (Percentage of Demand)
Academic & Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Who are the leading companies in Clinical Oncology Next Generation Sequencing Ngs
Illumina
Roche
Agilent Technologies
Knome
Genomatix Software
GATC Biotech
Oxford Nanopore Technologies
Macrogen
Life Technologies
DNASTAR
Exosome Diagnostics
Biomatters
CLC Bio
BGI
Qiagen
Perkin Elmer
Pacific Bioscience
Partek
GnuBIO
Foundation Medicine
Paradigm
Caris Life Sciences
Myriad Genetics
Clinical Oncology Next Generation Sequencing Ngs markets by region:
In North America
In Latin America
Europe
The Asia-pacific
Middle East and Africa (MEA)
What are the main countries covered
The United States
Canada
Germany
France
UK
Italy
Russia
China
Japan
Korea
Southeast Asia
India
Australia
Brazil
Mexico
Argentina
Chile
Colombia
Egypt
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Which is the most profitable market
Among regions, North America/Europe/Asia Pacific accounted for the largest share of global personalized beauty equipment as rising consumer incomes led to increased spending at Clinical Oncology Next Generation Sequencing Ngs.
What methodology did you follow in your research
This study was conducted by our expert analysts through a combination of primary and secondary studies. The methodology we follow includes a demand-side assessment of the market and triangulation of this through supply-side analysis. The methodology is based on the use of standard market structures, methods, and definitions.
Who were the primary study respondents
We talk to stakeholders across the spectrum. Including C-level executives, distributors, product manufacturers, industry experts, etc.
What are the sources of secondary research
We conduct extensive secondary studies using proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations and research papers.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Market Size Units
1.8 Review Cycle
2 Global Market Overview
2.1 Global Clinical Oncology Next Generation Sequencing Ngs Revenue and Growth Forecast 2014-2026
2.2 Global Clinical Oncology Next Generation Sequencing Ngs Market Size and Growth Forecast 2014-2026
2.3 Global Clinical Oncology Next Generation Sequencing Ngs Revenue by Region 2014-2026
2.4 Clinical Oncology Next Generation Sequencing Ngs Market Share by Major Regions 2014-2021
2.5 Clinical Oncology Next Generation Sequencing Ngs Gross Margin in Different Region 2014-2021
2.6 Global Clinical Oncology Next Generation Sequencing Ngs Market History Price and Forecast 2014-2026
2.7 Global Clinical Oncology Next Generation Sequencing Ngs Sales Market Share by Top Companies 2014-2021
3 Global Clinical Oncology Next Generation Sequencing Ngs Market by Type
3.1 Global Clinical Oncology Next Generation Sequencing Ngs Revenue and Growth Rate Segment by Types from 2014-2021
3.2 Global Clinical Oncology Next Generation Sequencing Ngs Market Size and Growth Rate Segment by Product Types from 2014-2021
3.3 Global Clinical Oncology Next Generation Sequencing Ngs Price Segment by Types from 2014-2021
3.4 Brief Introduction of Different Types
3.4.1 NGS Pre-Sequencing
3.4.2 Sequencing
3.4.3 NGS Data Analysis
3.4.4 Primary, Secondary & Tertiary Data Analysis
4 Global Clinical Oncology Next Generation Sequencing Ngs Market by Application
4.1 Global Clinical Oncology Next Generation Sequencing Ngs Revenue and Growth Rate Segment by Applications from 2014-2021
4.2 Global Clinical Oncology Next Generation Sequencing Ngs Market Size and Growth Rate Segment by Product Applications from 2014-2021
4.3 Brief Introduction of Different Applications
4.3.1 Academic & Clinical Research
4.3.2 Hospitals & Clinics
4.3.3 Pharma & Biotech Entities
5 North America Clinical Oncology Next Generation Sequencing Ngs Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
5.1 North America Clinical Oncology Next Generation Sequencing Ngs Value ($) from 2014-2021
5.2 North America Clinical Oncology Next Generation Sequencing Ngs Market Size from 2014-2021
5.3 North America Clinical Oncology Next Generation Sequencing Ngs Price Change from 2014-2021
5.4 North America Clinical Oncology Next Generation Sequencing Ngs Import and Export from 2014-2021
5.5 North America Clinical Oncology Next Generation Sequencing Ngs Market Value ($) and Growth (%) by Type from 2014-2021
5.6 North America Clinical Oncology Next Generation Sequencing Ngs Market Value ($) and Growth (%) by Application from 2014-2021
5.7 North America Clinical Oncology Next Generation Sequencing Ngs Market Value ($) and Growth (%) by Countries from 2014-2021
5.7.1 The United States
5.7.2 Canada
5.8 Top North America Clinical Oncology Next Generation Sequencing Ngs Participants Value ($) and Market Share (%) in 2020
6 Europe Clinical Oncology Next Generation Sequencing Ngs Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
6.1 Europe Clinical Oncology Next Generation Sequencing Ngs Value ($) from 2014-2021
6.2 Europe Clinical Oncology Next Generation Sequencing Ngs Market Size from 2014-2021
6.3 Europe Clinical Oncology Next Generation Sequencing Ngs Price Change from 2014-2021
6.4 Europe Clinical Oncology Next Generation Sequencing Ngs Import and Export from 2014-2021
6.5 Europe Clinical Oncology Next Generation Sequencing Ngs Market Value ($) and Growth (%) by Type from 2014-2021
6.6 Europe Clinical Oncology Next Generation Sequencing Ngs Market Value ($) and Growth (%) by Application from 2014-2021
6.7 Europe Clinical Oncology Next Generation Sequencing Ngs Market Value ($) and Growth (%) by Countries from 2014-2021
6.7.1 Germany
6.7.2 France
6.7.3 UK
6.7.4 Italy
6.7.5 Russia
…
6.8 Top Europe Clinical Oncology Next Generation Sequencing Ngs Participants Value ($) and Market Share (%) in 2020
7 Asia-Pacific Clinical Oncology Next Generation Sequencing Ngs Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
7.1 Asia-Pacific Clinical Oncology Next Generation Sequencing Ngs Value ($) from 2014-2021
7.2 Asia-Pacific Clinical Oncology Next Generation Sequencing Ngs Market Size from 2014-2021
7.3 Asia-Pacific Clinical Oncology Next Generation Sequencing Ngs Price Change from 2014-2021
7.4 Asia-Pacific Clinical Oncology Next Generation Sequencing Ngs Import and Export from 2014-2021
7.5 Asia-Pacific Clinical Oncology Next Generation Sequencing Ngs Market Value ($) and Growth (%) by Type from 2014-2021
7.6 Asia-Pacific Clinical Oncology Next Generation Sequencing Ngs Market Value ($) and Growth (%) by Application from 2014-2021
7.7 Asia-Pacific Clinical Oncology Next Generation Sequencing Ngs Market Value ($) and Growth (%) by Countries from 2014-2021
7.7.1 China
7.7.2 Japan
7.7.3 Korea
7.7.4 Southeast Asia
7.7.5 India
7.7.6 Australia
…
7.8 Top Asia-Pacific Clinical Oncology Next Generation Sequencing Ngs Participants Value ($) and Market Share (%) in 2020
8 Latin America Clinical Oncology Next Generation Sequencing Ngs Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
8.1 Latin America Clinical Oncology Next Generation Sequencing Ngs Value ($) from 2014-2021
8.2 Latin America Clinical Oncology Next Generation Sequencing Ngs Market Size from 2014-2021
8.3 Latin America Clinical Oncology Next Generation Sequencing Ngs Price Change from 2014-2021
8.4 Latin America Clinical Oncology Next Generation Sequencing Ngs Import and Export from 2014-2021
8.5 Latin America Clinical Oncology Next Generation Sequencing Ngs Market Value ($) and Growth (%) by Type from 2014-2021
8.6 Latin America Clinical Oncology Next Generation Sequencing Ngs Market Value ($) and Growth (%) by Application from 2014-2021
8.7 Latin America Clinical Oncology Next Generation Sequencing Ngs Market Value ($) and Growth (%) by Countries from 2014-2021
8.7.1 Brazil
8.7.2 Mexico
8.7.3 Argentina
8.7.4 Chile
8.7.5 Colombia
…
8.8 Top Latin America Clinical Oncology Next Generation Sequencing Ngs Participants Value ($) and Market Share (%) in 2020
9 Middle East & Africa Clinical Oncology Next Generation Sequencing Ngs Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
9.1 Middle East & Africa Clinical Oncology Next Generation Sequencing Ngs Value ($) from 2014-2021
9.2 Middle East & Africa Clinical Oncology Next Generation Sequencing Ngs Market Size from 2014-2021
9.3 Middle East & Africa Clinical Oncology Next Generation Sequencing Ngs Price Change from 2014-2021
9.4 Middle East & Africa Clinical Oncology Next Generation Sequencing Ngs Import and Export from 2014-2021
9.5 Middle East & Africa Clinical Oncology Next Generation Sequencing Ngs Market Value ($) and Growth (%) by Type from 2014-2021
9.6 Middle East & Africa Clinical Oncology Next Generation Sequencing Ngs Market Value ($) and Growth (%) by Application from 2014-2021
9.7 Middle East & Africa Clinical Oncology Next Generation Sequencing Ngs Market Value ($) and Growth (%) by Countries from 2014-2021
9.7.1 Egypt
9.7.2 Saudi Arabia
9.7.3 United Arab Emirates
9.7.4 Nigeria
9.7.5 South Africa
…
9.8 Top Middle East & Africa Clinical Oncology Next Generation Sequencing Ngs Participants Value ($) and Market Share (%) in 2020
10. Global Level Competitive Intelligence – Company Profiles
10.1 Illumina
10.1.1 Illumina Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.1.2 Illumina Sales, Value, Gross and Gross Margin from 2014-2021
10.1.3 Illumina Value and Growth Change from 2014-2021
10.1.4 Illumina Price Change from 2014-2021
10.1.5 Illumina Product Offered
10.2 Roche
10.2.1 Roche Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.2.2 Roche Sales, Value, Gross and Gross Margin from 2014-2021
10.2.3 Roche Value and Growth Change from 2014-2021
10.2.4 Roche Price Change from 2014-2021
10.2.5 Roche Product Offered
10.3 Agilent Technologies
10.3.1 Agilent Technologies Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.3.2 Agilent Technologies Sales, Value, Gross and Gross Margin from 2014-2021
10.3.3 Agilent Technologies Value and Growth Change from 2014-2021
10.3.4 Agilent Technologies Price Change from 2014-2021
10.3.5 Agilent Technologies Product Offered
10.4 Knome
10.4.1 Knome Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.4.2 Knome Sales, Value, Gross and Gross Margin from 2014-2021
10.4.3 Knome Value and Growth Change from 2014-2021
10.4.4 Knome Price Change from 2014-2021
10.4.5 Knome Product Offered
10.5 Genomatix Software
10.5.1 Genomatix Software Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.5.2 Genomatix Software Sales, Value, Gross and Gross Margin from 2014-2021
10.5.3 Genomatix Software Value and Growth Change from 2014-2021
10.5.4 Genomatix Software Price Change from 2014-2021
10.5.5 Genomatix Software Product Offered
10.6 GATC Biotech
10.6.1 GATC Biotech Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.6.2 GATC Biotech Sales, Value, Gross and Gross Margin from 2014-2021
10.6.3 GATC Biotech Value and Growth Change from 2014-2021
10.6.4 GATC Biotech Price Change from 2014-2021
10.6.5 GATC Biotech Product Offered
10.7 Oxford Nanopore Technologies
10.7.1 Oxford Nanopore Technologies Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.7.2 Oxford Nanopore Technologies Sales, Value, Gross and Gross Margin from 2014-2021
10.7.3 Oxford Nanopore Technologies Value and Growth Change from 2014-2021
10.7.4 Oxford Nanopore Technologies Price Change from 2014-2021
10.7.5 Oxford Nanopore Technologies Product Offered
10.8 Macrogen
10.8.1 Macrogen Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.8.2 Macrogen Sales, Value, Gross and Gross Margin from 2014-2021
10.8.3 Macrogen Value and Growth Change from 2014-2021
10.8.4 Macrogen Price Change from 2014-2021
10.8.5 Macrogen Product Offered
10.9 Life Technologies
10.9.1 Life Technologies Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.9.2 Life Technologies Sales, Value, Gross and Gross Margin from 2014-2021
10.9.3 Life Technologies Value and Growth Change from 2014-2021
10.9.4 Life Technologies Price Change from 2014-2021
10.9.5 Life Technologies Product Offered
10.10 DNASTAR
10.10.1 DNASTAR Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.10.2 DNASTAR Sales, Value, Gross and Gross Margin from 2014-2021
10.10.3 DNASTAR Value and Growth Change from 2014-2021
10.10.4 DNASTAR Price Change from 2014-2021
10.10.5 DNASTAR Product Offered
10.11 Exosome Diagnostics
10.11.1 Exosome Diagnostics Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.11.2 Exosome Diagnostics Sales, Value, Gross and Gross Margin from 2014-2021
10.11.3 Exosome Diagnostics Value and Growth Change from 2014-2021
10.11.4 Exosome Diagnostics Price Change from 2014-2021
10.11.5 Exosome Diagnostics Product Offered
10.12 Biomatters
10.12.1 Biomatters Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.12.2 Biomatters Sales, Value, Gross and Gross Margin from 2014-2021
10.12.3 Biomatters Value and Growth Change from 2014-2021
10.12.4 Biomatters Price Change from 2014-2021
10.12.5 Biomatters Product Offered
10.13 CLC Bio
10.13.1 CLC Bio Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.13.2 CLC Bio Sales, Value, Gross and Gross Margin from 2014-2021
10.13.3 CLC Bio Value and Growth Change from 2014-2021
10.13.4 CLC Bio Price Change from 2014-2021
10.13.5 CLC Bio Product Offered
10.14 BGI
10.14.1 BGI Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.14.2 BGI Sales, Value, Gross and Gross Margin from 2014-2021
10.14.3 BGI Value and Growth Change from 2014-2021
10.14.4 BGI Price Change from 2014-2021
10.14.5 BGI Product Offered
10.15 Qiagen
10.15.1 Qiagen Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.15.2 Qiagen Sales, Value, Gross and Gross Margin from 2014-2021
10.15.3 Qiagen Value and Growth Change from 2014-2021
10.15.4 Qiagen Price Change from 2014-2021
10.15.5 Qiagen Product Offered
10.16 Perkin Elmer
10.16.1 Perkin Elmer Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.16.2 Perkin Elmer Sales, Value, Gross and Gross Margin from 2014-2021
10.16.3 Perkin Elmer Value and Growth Change from 2014-2021
10.16.4 Perkin Elmer Price Change from 2014-2021
10.16.5 Perkin Elmer Product Offered
10.17 Pacific Bioscience
10.17.1 Pacific Bioscience Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.17.2 Pacific Bioscience Sales, Value, Gross and Gross Margin from 2014-2021
10.17.3 Pacific Bioscience Value and Growth Change from 2014-2021
10.17.4 Pacific Bioscience Price Change from 2014-2021
10.17.5 Pacific Bioscience Product Offered
10.18 Partek
10.18.1 Partek Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.18.2 Partek Sales, Value, Gross and Gross Margin from 2014-2021
10.18.3 Partek Value and Growth Change from 2014-2021
10.18.4 Partek Price Change from 2014-2021
10.18.5 Partek Product Offered
10.19 GnuBIO
10.19.1 GnuBIO Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.19.2 GnuBIO Sales, Value, Gross and Gross Margin from 2014-2021
10.19.3 GnuBIO Value and Growth Change from 2014-2021
10.19.4 GnuBIO Price Change from 2014-2021
10.19.5 GnuBIO Product Offered
10.20 Foundation Medicine
10.20.1 Foundation Medicine Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.20.2 Foundation Medicine Sales, Value, Gross and Gross Margin from 2014-2021
10.20.3 Foundation Medicine Value and Growth Change from 2014-2021
10.20.4 Foundation Medicine Price Change from 2014-2021
10.20.5 Foundation Medicine Product Offered
10.21 Paradigm
10.21.1 Paradigm Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.21.2 Paradigm Sales, Value, Gross and Gross Margin from 2014-2021
10.21.3 Paradigm Value and Growth Change from 2014-2021
10.21.4 Paradigm Price Change from 2014-2021
10.21.5 Paradigm Product Offered
10.22 Caris Life Sciences
10.22.1 Caris Life Sciences Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.22.2 Caris Life Sciences Sales, Value, Gross and Gross Margin from 2014-2021
10.22.3 Caris Life Sciences Value and Growth Change from 2014-2021
10.22.4 Caris Life Sciences Price Change from 2014-2021
10.22.5 Caris Life Sciences Product Offered
10.23 Myriad Genetics
10.23.1 Myriad Genetics Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.23.2 Myriad Genetics Sales, Value, Gross and Gross Margin from 2014-2021
10.23.3 Myriad Genetics Value and Growth Change from 2014-2021
10.23.4 Myriad Genetics Price Change from 2014-2021
10.23.5 Myriad Genetics Product Offered
11. Market Dynamics
11.1 Driving Factors
11.1.1 Rising Demand in Some Regions: North America/Europe/China/India/Japan …
11.1.2 Increasing Use of Clinical Oncology Next Generation Sequencing Ngs by Different End-User/Applications
11.2 Restraints and Challenges in the Market
11.3 Opportunities
11.4 Covid-19 Impact/Evaluation
12. Future Forecast of Global Clinical Oncology Next Generation Sequencing Ngs Market from 2020-2026
12.1 Future Forecast of Global Clinical Oncology Next Generation Sequencing Ngs Market from 2020-2026 Segment by Regions
12.2 Future Forecast of Global Clinical Oncology Next Generation Sequencing Ngs Market from 2020-2026 Segment by Type
12.3 Future Forecast of Global Clinical Oncology Next Generation Sequencing Ngs Market from 2020-2026 Segment by Application
13. Investment Analysis
13.1 Fundamental Analysis (Porter's Five Forces Analysis)
13.2 Technical Preparation Analysis
13.3 Risk Evaluating Analysis
13.4 Estimated Investment Pay-Back Period
14 Research Methodology
14.1 Research Data
14.1.1 Secondary Data
14.1.2 Primary Data
14.2 Revenue Estimation
14.2.1 Bottom-Up Approach
14.2.2 Top-Down Approach (Involves time, Space, and Persons)
14.3 Data Triangulation
14.4 Assumptions
14.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
14.6 Limitations of Our Study
14.7 Scene Based Modeling
15 Disclaimer
Research Methodology:
Clinical Oncology Next Generation Sequencing Ngs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|